Edgestream Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.53M | Sell |
32,383
-5,851
| -15% | -$472K | 0.08% | 450 |
|
|
2026
Q1 | $3.31M | Buy |
38,234
+17,686
| +86% | +$1.69M | 0.11% | 353 |
|
|
2025
Q4 | $1.97M | Buy |
20,548
+9,124
| +80% | +$886K | 0.06% | 541 |
|
|
2025
Q3 | $1.09M | Buy |
+11,424
| New | +$1.05M | 0.03% | 617 |
|
|
2025
Q2 | – | Sell |
-3,621
| Closed | -$325K | – | 987 |
|
|
2025
Q1 | $325K | Buy |
+3,621
| New | +$324K | 0.01% | 743 |
|
|
2024
Q4 | – | Sell |
-23,737
| Closed | -$2.14M | – | 999 |
|
|
2024
Q3 | $2.14M | Buy |
23,737
+20,705
| +683% | +$1.74M | 0.09% | 385 |
|
|
2024
Q2 | $239K | Buy |
+3,032
| New | +$249K | 0.01% | 783 |
|
|
2023
Q4 | – | Sell |
-2,977
| Closed | -$233K | – | 972 |
|
|
2023
Q3 | $233K | Buy |
+2,977
| New | +$249K | 0.02% | 763 |
|
|
2023
Q2 | – | Sell |
-3,599
| Closed | -$290K | – | 830 |
|
|
2023
Q1 | $290K | Sell |
3,599
-54,380
| -94% | -$4.43M | 0.03% | 476 |
|
|
2022
Q4 | $4.51M | Buy |
57,979
+53,462
| +1,184% | +$4.33M | 0.51% | 39 |
|
|
2022
Q3 | $365K | Sell |
4,517
-4,741
| -51% | -$426K | 0.03% | 381 |
|
|
2022
Q2 | $831K | Sell |
9,258
-1,447
| -14% | -$147K | 0.07% | 352 |
|
|
2022
Q1 | $1.19M | Sell |
10,705
-238,648
| -96% | -$25.2M | 0.09% | 303 |
|
|
2021
Q4 | $25.8M | Buy |
249,353
+245,888
| +7,096% | +$28.5M | 1.61% | 4 |
|
|
2021
Q3 | $434K | Sell |
3,465
-74,292
| -96% | -$9.62M | 0.03% | 402 |
|
|
2021
Q2 | $9.65M | Buy |
77,757
+24,448
| +46% | +$3.07M | 0.57% | 47 |
|
|
2021
Q1 | $6.3M | Buy |
53,309
+29,840
| +127% | +$3.5M | 0.35% | 107 |
|
|
2020
Q4 | $2.75M | Buy |
+23,469
| New | +$2.58M | 0.14% | 189 |
|
|
2020
Q3 | – | Sell |
-13,839
| Closed | -$1.27M | – | 332 |
|
|
2020
Q2 | $1.27M | Sell |
13,839
-13,743
| -50% | -$1.32M | 0.07% | 228 |
|
|
2020
Q1 | $2.49M | Buy |
+27,582
| New | +$2.93M | 0.23% | 122 |
|
|
2019
Q2 | – | Sell |
-43,773
| Closed | -$3.99M | – | 264 |
|
|
2019
Q1 | $3.99M | Buy |
+43,773
| New | +$3.92M | 0.58% | 56 |
|
|
2017
Q2 | – | Sell |
-7,146
| Closed | -$576K | – | 141 |
|
|
2017
Q1 | $576K | Buy |
+7,146
| New | +$558K | 0.25% | 86 |
|
|
2016
Q4 | – | Sell |
-16,306
| Closed | -$1.41M | – | 117 |
|
|
2016
Q3 | $1.41M | Buy |
+16,306
| New | +$1.42M | 0.78% | 35 |
|
Other funds holding MDT
Edgestream Partners's MDT Position: Q2 2026 in Review
Edgestream Partners reduced its Medtronic (MDT) stake by 15% in Q2 2026, selling an estimated $472K and leaving 32,383 shares worth $2.53M. The position accounts for 0.08% of the portfolio, ranked #450.
Edgestream Partners first reported a position in MDT in Q3 2016 and has held it in 23 quarters since. The position peaked at $25.8M in Q4 2021. 2,133 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Edgestream Partners held 32,383 shares of Medtronic worth $2.53M as of Q2 2026.
- Edgestream Partners sold 5,851 Medtronic shares in Q2 2026, an estimated $472K.
- Medtronic made up 0.08% of Edgestream Partners's portfolio in Q2 2026, its #450 holding.
- Edgestream Partners first reported a position in Medtronic in Q3 2016 and has held it in 23 quarters since.
- Edgestream Partners's Medtronic position peaked at $25.8M in Q4 2021.
- 2,133 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.